97 related articles for article (PubMed ID: 25822574)
21. [Prostate cancer screening in France: Results from the EDIFICE surveys].
Morère JF; Touboul C; Lhomel C; Rouprêt M
Prog Urol; 2020 May; 30(6):332-338. PubMed ID: 32331954
[TBL] [Abstract][Full Text] [Related]
22. A community study using specified and unspecified scenarios to investigate men's views about PSA screening.
Gattellari M; Ward JE
Health Expect; 2004 Dec; 7(4):274-89. PubMed ID: 15544681
[TBL] [Abstract][Full Text] [Related]
23. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
24. Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.
Shoag J; Halpern JA; Lee DJ; Mittal S; Ballman KV; Barbieri CE; Hu JC
J Urol; 2016 Oct; 196(4):1047-52. PubMed ID: 27060052
[TBL] [Abstract][Full Text] [Related]
25. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden.
Jonsson H; Holmström B; Duffy SW; Stattin P
Int J Cancer; 2011 Oct; 129(8):1881-8. PubMed ID: 21154740
[TBL] [Abstract][Full Text] [Related]
26. Why do men refuse prostate cancer screening? Demographic analysis in Turkey.
Ceber E; Cakir D; Ogce F; Simsir A; Cal C; Ozentürk G
Asian Pac J Cancer Prev; 2008; 9(3):387-90. PubMed ID: 18990007
[TBL] [Abstract][Full Text] [Related]
27. Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.
Viguier J; Morère JF; Pivot X; Touboul C; Lhomel C; Couraud S; de La Motte Rouge T; Eisinger F
Curr Oncol Rep; 2018 Mar; 20(Suppl 1):14. PubMed ID: 29508088
[TBL] [Abstract][Full Text] [Related]
28. Impact of general practitioners' sex and age on systematic recommendation for cancer screening.
Eisinger F; Pivot X; Coscas Y; Viguier J; Calazel-Benque A; Blay JY; Roussel C; Morère JF
Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S39-41. PubMed ID: 21245680
[TBL] [Abstract][Full Text] [Related]
29. Breast, colon, and prostate screening in the adult population of Croatia: does rural origin matter?
Polasek O; Kolcic I; Voncina L; Strnad M; Vuletic S; Kern J
Rural Remote Health; 2007; 7(3):749. PubMed ID: 17900222
[TBL] [Abstract][Full Text] [Related]
30. Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the U.S. Preventive Services Task Force Recommendation.
Ong MS; Mandl KD
Ann Intern Med; 2017 Mar; 166(6):451-452. PubMed ID: 28320011
[No Abstract] [Full Text] [Related]
31. Design-corrected variation by centre in mortality reduction in the ERSPC randomised prostate cancer screening trial.
Hakama M; Moss SM; Stenman UH; Roobol MJ; Zappa M; Carlsson S; Randazzo M; Nelen V; Hugosson J
J Med Screen; 2017 Jun; 24(2):98-103. PubMed ID: 27510947
[TBL] [Abstract][Full Text] [Related]
32. Impact of a printed decision aid on patients' intention to undergo prostate cancer screening: a multicentre, pragmatic randomised controlled trial in primary care.
Tran VT; Kisseleva-Romanova E; Rigal L; Falcoff H
Br J Gen Pract; 2015 May; 65(634):e295-304. PubMed ID: 25918334
[TBL] [Abstract][Full Text] [Related]
33. Rural residence and prostate cancer screening with prostate-specific antigen.
Stamatiou K; Skolarikos A
Rural Remote Health; 2009; 9(2):1227. PubMed ID: 19594290
[TBL] [Abstract][Full Text] [Related]
34. Effects of an Educational Program for Prostate Cancer Prevention on knowledge and PSA Testing in Men Over 50 Years old in Community Areas of Shiraz in 2016.
Molazem Z; Ebadi M; Khademian M; Zare R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):633-637. PubMed ID: 29580031
[TBL] [Abstract][Full Text] [Related]
35. The prostate cancer screening clinic in the Bahamas: a model for low- and middle-income countries.
Roberts R; Mitchell C; Tancawan AL; Pedican M; Jones GW
Cancer Causes Control; 2017 Nov; 28(11):1187-1193. PubMed ID: 29119339
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
Kitagawa Y; Namiki M
Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
[TBL] [Abstract][Full Text] [Related]
37. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
38. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
39. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey.
Swan J; Breen N; Coates RJ; Rimer BK; Lee NC
Cancer; 2003 Mar; 97(6):1528-40. PubMed ID: 12627518
[TBL] [Abstract][Full Text] [Related]
40. Prostate-specific antigen screening: An update of physician beliefs and practices.
Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
